Lv4
468 积分 2023-04-11 加入
Anti-CD20 monoclonal antibodies in multiple sclerosis: Rethinking the current treatment strategy
2天前
已完结
LRRK2-targeting antisense oligonucleotide in Parkinson’s disease: a phase 1 randomized controlled trial
8天前
已完结
Here’s why China’s science and innovation model is thriving
3个月前
已完结
Confirmatory population pharmacokinetic analysis for bapineuzumab phase 3 studies in patients with mild to moderate Alzheimer's disease
3个月前
已完结
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
4个月前
已完结
Impact of Pre-analytical Factors on Fluid Biomarker Measurements in Alzheimer Disease
4个月前
已完结
The genetic architecture of Parkinson's disease
5个月前
已完结
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
5个月前
已完结
Baseline Characteristics from Evoke and Evoke+: Two Phase 3 Randomized Placebo-controlled Trials of Oral Semaglutide in Patients with Early Alzheimer’s Disease (P11-9.013)
6个月前
已完结
Ultrasound-mediated blood–brain barrier opening: An effective drug delivery system for theranostics of brain diseases
6个月前
已完结
皖公网安备34019202002308
